Hinokiflavone from Platycladi cacumen as a potent broad-spectrum inhibitor of gut microbial Loop-1 β-glucuronidases: Inhibition kinetics and molecular simulation

Yue Han,Yu-Tong Liu,Lu Chen,Hao-Fan Sun,Guang-Hao Zhu,Dong-Ning Kang,Qi Zhou,Hui Tang,Yu-Ling Yin,Jie Hou
DOI: https://doi.org/10.1016/j.cbi.2024.111261
IF: 5.168
2024-10-11
Chemico-Biological Interactions
Abstract:Gut microbial Loop-1 β-glucuronidases (gmGUS) played an important role in irinotecan-induced gastrointestinal toxicity by regulating the level of its active metabolite SN38 through enterohepatic recirculation. gmGUS inhibition has emerged as a promising approach to relieve its dose-limiting intestinal toxicity and improve its medication efficacy. This study aims to investigate the inhibitory effects and mechanisms of Platycladi cacumen and its main constituent hinokiflavone against four different types of Loop-1 gmGUS ( Ee GUS, Sa GUS, Cp GUS and Ec GUS). Our results showed that the ethanol extract of Platycladi cacumen displayed strong broad-spectrum inhibition against four gmGUS, and hinokiflavone could potently inhibit Ee GUS, Sa GUS, Cp GUS and Ec GUS with IC 50 values of 0.09 ± 0.01 μM, 0.44 ± 0.01 μM, 0.20 ± 0.01 μM and 0.69 ± 0.10 μM, respectively. Inhibition kinetic analyses demonstrated that hinokiflavone acted as a strong competitive inhibitor of Ee GUS with K i value of 0.13 μM, while it displayed non-competitive inhibition against Sa GUS, Cp GUS and Ec GUS, with the K i values of 0.43 μM, 0.33 μM and 0.76 μM, respectively. Docking simulations revealed that hinokiflavone could tightly bind with Tyr-485 and Glu-516 in catalytic sites of E eGUS, as well it created strong interactions with amino acids in loop structures of Sa GUS (Asn-362), Cp GUS (Phe-363, Met-364, Ala-365 and Arg-375) and Ec GUS (Leu-361) to interfere the substrate entry into the catalytic pocket. Collectively, these results confirmed that hinokiflavone from Platycladi cacumen is a potent naturally occurring inhibitor of gmGUS with broad efficiency, suggesting hinokiflavone will be helpful for alleviating intestinal toxicity in irinotecan therapy.
pharmacology & pharmacy,biochemistry & molecular biology,toxicology
What problem does this paper attempt to address?